The role of dorsal striatal GABA(A) receptors in dopamine agonist- induced behavior and neuropeptide gene expression

Brain Research

Volumn 836, Issue 1-2, 1999, Pages 99-109

  Jones, Elizabeth A ^a   Wang, John Q ^a   Mayer, Denise C ^a   McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Amphetamine; GABA; In situ hybridization; Neuropeptide; SKF 82958; Striatum

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID A RECEPTOR; AMPHETAMINE; BICUCULLINE; DOPAMINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; NEUROPEPTIDE; PREPRODYNORPHIN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; GENE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; SNIFFING;

ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; BICUCULLINE; CORPUS STRIATUM; DOPAMINE AGONISTS; FUNCTIONAL LATERALITY; GABA ANTAGONISTS; GENE EXPRESSION REGULATION; MALE; NEUROPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SUBSTANTIA NIGRA;

EID: 0033620839     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01617-0     Document Type: Article

References (42)

1. 1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J. Neurosci. 17:1997;8498-8505.
2. B receptors differentially regulate acetlycholine release in vivo. Neurosci. Lett. 160:1993;126-130.
3. Bloch B., Le Moine C. Neostriatal dopamine receptors. Trends Neurosci. 17:1994;3-4.
4. Bolam J.P., Powell J.F., Wu J.Y., Smith A.D. Glutamate decarboxylase-immunoreactive structures in the rat neostriatum: a correlated light and electron microscope study including a combination of Golgi impregnation with immunocytochemistry. J. Comp. Neurol. 237:1985;1-20.
5. Bourgoin S., Artaud F., Cesselin F., Glowinski J., Hamon M. Local and remote effects of intra-caudate administration of GABA-related drugs on met-enkephalin release in the basal ganglia. Brain Res. 361:1985;361-372.
6. Brann M.R., Emson P.C. Microiontophoretic injection of fluorescent tracer combined with simultaneous immunofluorescent histochemistry for the demonstration of efferents from the caudate-putamen projecting to the globus pallidus. Neurosci. Lett. 16:1980;61-65.
7. Cavalheiro E.A., Bortolotto Z.A., Turski L. Microinjections of the γ-aminobutyrate antagonist, bicuculline methiodide, into the caudate-putamen prevent amygdala-kindled seizures in rats. Brain Res. 411:1987;370-372.
8. Cowan R.L., Wilson C.J., Emson P.C., Heizmann C.W. Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J. Comp. Neurol. 302:1980;197-205.
9. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
10. Dickson P.R., Lang C.G., Hinton S.C., Kelley A.E. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience. 61:1994;81-91.
11. Ellinwood E.H., Balster R.L. Rating the behavioral effects of amphetamine. Eur. J. Pharmacol. 28:1974;35-41.
12. Erdtsieck-Ernste E.B., Feenstra M.G., Botterblom M.H., Van Uum H.F., Sluiter A.A., Heinsbroek R.P. c-fos expression in the rat brain after pharmacological stimulation of the rat "mediodorsal" thalamus by means of microdialysis. Neuroscience. 66:1995;115-131.
13. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
14. 3H ] γ-amino butyric acid in the rat neostriatum: II. Opposing effects of the D1 and D2 dopamine receptor stimulation in the dorsal caudate-putamen Neuroscience. 19:1986;1109-1117.
15. Harsing L.G. Jr., Yang H.-Y.T., Costa E. Evidence of γ-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of met-enkephalin elicited by depolarization. J. Pharmacol. Exp. Ther. 220:1982;616-620.
16. 2 interactions and non-synaptic influences. Neuroscience. 77:1997;419-429.
17. Hurd Y.L., Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol. Brain. Res. 16:1992;97-104.
18. Jaeger D., Kita H., Wilson C.J. Surround inhibition among projection neurons is weak or nonexistent in the rat neostriatum. J. Neurophysiol. 72:1994;2555-2558.
19. Jolkkonen J., Jenner P., Marsden C.D. GABAergic modulation of striatal peptide expression in rats and the alteration induced by dopamine antagonist treatment. Neurosci. Lett. 180:1994;273-276.
20. Karler R., Calder L.D., Thai L.M., Bedingfield J.B. A dopaminergic-glutaminergic basis for the action of amphetamine and cocaine. Brain Res. 658:1994;8-14.
21. Karler R., Calder L.D., Thai L.M., Bedingfield J.B. The dopaminergic, glutaminergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res. 671:1995;100-104.
22. 1 dopamine receptor-mediated induction of zif/268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367:1996;165-176.
23. A.E. Kelley, Measurement of rodent stereotyped behavior, in: Current Protocols in Neuroscience, Wiley, New York, NY, 1997, pp. 8.81-8.813.
24. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNA's in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
25. M. Linton, P.S. Gallo (Eds.), Ordered data, in: The Practical Statistician: Simplified Handbook of Statistics, Wadsworth Publishing, Belmont, CA, 1975, 99 pp.
26. Mogenson G.J., Swanson L.W., Wu M. Neural projections from nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: an anatomical and electrophysiological investigation in the rat. J. Neurosci. 3:1983;189-202.
27. A antagonist and nicotine-induced antinociception. Life Sci. 61:1997;221-225.
28. Oishi T., Mikami A., Kubota K. Local injection of bicuculline into area 8 and area 6 of the rhesus monkey induces deficits in performance of a visual discrimination GO/NO-GO task. Neurosci. Res. 22:1995;163-177.
29. Reimer S., Holt V. GABAergic regulation of striatal opioid gene expression. Mol. Brain Res. 10:1991;49-54.
30. J. Scheel-Kruger, G. Magelund, M. Olianas, The role of GABA in the basal ganglia and limbic system for behavior, in: F.V. DeFeudis, P. Mandel (Eds.), Amino Acid Neurotransmitters, Raven Press, New York, 1981, pp. 23-36.
31. Schmit B., Dimicco J.A. Blockade of GABA receptors in periventricular forebrain of anesthetized cats: effects on heart rate, arterial pressure and hindlimb vascular resistance. Brain Res. 301:1984;111-119.
32. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:1993;53-59.
33. Smith A.J.W., McGinty J.F. Acute amphetamine or metamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res. 21:1994;359-362.
34. Stratford T.R., Kelley A.E. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J. Neurosci. 17:1997;4434-4440.
35. Turski L., Diedrichs S., Klockgether T., Schwarz M., Turski W.A., Sontag K.H., Bortolotto Z.A., Calderazzo-Filho L.S., Cavalheiro E.A. Paradoxical anticonvulsant activity of the γ-aminobutyrate antagonist bicuculline methiodide in the rat striatum. Synapse. 7:1991;14-20.
36. Wang J.Q., Smith A.J.W., McGinty J.F. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience. 68:1995;83-95.
37. Wang J.Q., McGinty J.F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine and methamphetamine in rat forebrain. J. Pharmacol. Exp. Ther. 273:1995;909-917.
38. J.Q. Wang, J.F. McGinty, Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum, in: K.M. Merchant (Ed.), Pharmacological Regulation of Gene Expression in the CNS, CRC Press, Boca Raton, 1996, pp. 81-113.
39. Wang J.Q., McGinty J.F. The full dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. J. Pharmacol. Exp. Ther. 281:1997;972-982.
40. Wang J.Q., McGinty J.F. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 748:1997;62-70.
41. Young W.S. III, Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA. 83:1986;9827-9831.
42. Yung K.K.L., Smith A.D., Levey A.I., Bolam J.P. Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur. J. Neurosci. 8:1996;861-869.